Advances in understanding COPD.

Area of Science:

• Pulmonary Medicine
• Molecular Biology
• Pharmacology

Background:

• Chronic obstructive pulmonary disease (COPD) is a growing global health concern with increasing scientific interest.
• Existing research focuses on understanding the complex molecular biology of COPD, its comorbidities, and the asthma COPD overlap syndrome (ACOS).
• Despite advances in basic science, the clinical application of these findings into new COPD therapies is progressing slowly.

Approach:

• This review selectively examines emerging themes in COPD research.
• It analyzes the sophisticated molecular pathways involved in COPD, comorbidities, and ACOS.
• The review also addresses obstacles hindering the translation of basic science discoveries into clinical treatments.

Key Points:

• New classes of COPD medicines are being developed based on emerging molecular pathways.
• Understanding comorbidities and asthma COPD overlap syndrome (ACOS) is crucial for comprehensive COPD management.
• The slow pace of clinical translation is a major bottleneck in developing novel COPD treatments.

Conclusions:

• Advances in understanding COPD's molecular basis offer potential for innovative therapies.
• Overcoming the challenges in clinical translation is essential to bring new COPD treatments to patients.
• Future efforts should focus on bridging the gap between basic science discoveries and effective clinical interventions for COPD.